dcc_tumour_subtype
Acute Lymphoblastic Leukemia
Acute myeloid leukaemia & Chronic myelogenous leukaemia
Acute myeloid leukemia
Adenocarcinoma
Adenocarcinoma, non-Western
Asian phenotype
CLL with mutated and unmutated IgVH
Cervical squamous cell carcinoma
Cholangiocarcinoma
Clear cell carcinoma
Clear cell renal cell carcinoma
Cutaneous melanoma
Diffuse Large B Cell Lymphoma
Ductal & lobular
Ductal adenocarcinoma
ER positive, HER2 negative
Early onset
Endocrine neoplasm
Enteropancreatic endocrine tumors and rare pancreatic exocrine tumors
Esophageal adenocarcinoma
Germinal center B-cell derived lymphomas
Gingivobuccal
Glioblastoma multiforme
Hepatocellular carcinoma
Hepatocellular carcinoma (Secondary to alcohol and adiposity)
Hepatocellular carcinoma (Virus-associated)
Hepatocellular carcinoma HBV-associated
Intestinal- and diffuse-type
Invasive urothelial bladder cancer
Lower grade glioma
Medulloblastoma and Pediatric pilocytic
Multiple rare subtypes
Myelodysplastic syndromes, myeloproliferative neoplasms & other chronic myeloid malignancies
Nasopharyngeal carcinoma, Asia
Neuroblastoma
Osteosarcoma/chondrosarcoma/rare subtypes
Papillary carcinoma
Papillary thyroid carcinoma
Pediatric medulloblastoma
Renal cell carcinoma (Focus on but not limited to clear cell subtype)
Retinoblastoma
Serous cystadenocarcinoma
Sqamous cell carcinoma of oral cavity/oropharynx/sinonasal cavity
Squamous carcinoma
Squamous cell carcinoma
Subtype defined by an amplification of the HER2 gene
Thyroid carcinoma
Triple negative
Triple negative/lobular/other
Urothelial carcinoma
Uterine corpus endometrial carcinoma
